Myrexis Competitors and Similar CompaniesClear all
Takeda's competitors and similar companies include Merrimack Pharmaceuticals and Oncopeptides.
 Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Merrimack Pharmaceuticals Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. | ||
Founding Date | Founding Date 1781 | Founding Date 2000 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US | |
Employees | Employees 47,4554% decrease | Employees 2763% decrease | Employees 80 |
Valuation ($) | Valuation ($) 43.7 b | Valuation ($) 223.7 m | Valuation ($) 42.4 m |
Financial | |||
Revenue (est.) | Revenue (est.) ¥4.5t (FY, 2026) | Revenue (est.) N/A | Revenue (est.) kr71.1m (FY, 2025) |
Cost of goods | Cost of goods ¥850.5b (FY, 2026) | Cost of goods N/A | Cost of goods kr2.5m (FY, 2025) |
Gross profit | Gross profit ¥3.7t (FY, 2026) | Gross profit N/A | Gross profit kr72m (FY, 2025) |
Net income | Net income ¥192b (FY, 2026) | Net income ($1.2m) (FY, 2023) | Net income (kr249.6m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 57.8m | Total funding raised $ 79.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
27
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
View company
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company